Insulin Inhibits Acetylcholine Responses in Rat Isolated Mesenteric Arteries via a Non-Nitric Oxide Nonprostanoid Pathway
暂无分享,去创建一个
[1] K. Ohashi,et al. Inhibitory effect of insulin on bradykinin‐induced venodilation , 2000, Journal of hypertension.
[2] M. Ujhelyi,et al. EDHF-mediated relaxation is impaired in fructose-fed rats. , 1999, Journal of cardiovascular pharmacology.
[3] A. Dart,et al. Lipids and the endothelium. , 1999, Cardiovascular research.
[4] R. Cannon,et al. Vasodilator response to systemic but not to local hyperinsulinemia in the human forearm. , 1998, Hypertension.
[5] R. Rizza,et al. Insulin and insulin-like growth factor-I cause coronary vasorelaxation in vitro. , 1998, Hypertension.
[6] L. Ragolia,et al. Vascular smooth muscle cell growth and insulin regulation of mitogen-activated protein kinase in hypertension. , 1998, The American journal of physiology.
[7] M. Hoenig,et al. Mechanisms of Impaired Endothelial Function Associated with Insulin Resistance , 1998, Journal of cardiovascular pharmacology and therapeutics.
[8] Y. Gomita,et al. Involvement of calcitonin gene‐related peptide (CGRP) receptors in insulin‐induced vasodilatation in mesenteric resistance blood vessels of rats , 1998, British journal of pharmacology.
[9] A. Adeagbo,et al. Calcium-Dependent Phospholipase A2 Mediates the Production of Endothelium-Derived Hyperpolarizing Factor in Perfused Rat Mesenteric Prearteriolar Bed , 1998, Journal of Vascular Research.
[10] A. Takeshita,et al. Importance of endothelium-derived hyperpolarizing factor in human arteries. , 1997, The Journal of clinical investigation.
[11] Y Nishikawa,et al. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. , 1997, Circulation.
[12] R Busse,et al. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. , 1996, Circulation.
[13] P. Raskin,et al. Relationship between insulin sensitivity, hyperinsulinemia, and insulin-mediated sympathetic activation in normotensive and hypertensive subjects. , 1996, American journal of hypertension.
[14] M. Fujishima,et al. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. , 1996, Journal of cardiovascular pharmacology.
[15] L. Ghiadoni,et al. Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. , 1996, Circulation.
[16] S. Hunt,et al. Hypertension, dyslipidemia, and insulin resistance: links in a chain or spokes on a wheel? , 1996, Current opinion in lipidology.
[17] N. Kaplan. The deadly quartet and the insulin resistance syndrome: an historical overview. , 1996, Hypertension research : official journal of the Japanese Society of Hypertension.
[18] E. Ferrannini,et al. Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension. , 1995, Circulation.
[19] L. Blatter,et al. Simultaneous measurements of Ca2+ and nitric oxide in bradykinin-stimulated vascular endothelial cells. , 1995, Circulation research.
[20] A. Quyyumi,et al. Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. , 1995, Circulation.
[21] T. Saruta,et al. Multiple factors contribute to acetylcholine-induced renal afferent arteriolar vasodilation during myogenic and norepinephrine- and KCl-induced vasoconstriction. Studies in the isolated perfused hydronephrotic kidney. , 1994, Circulation research.
[22] D. Webb,et al. Local L-NG-monomethyl-arginine attenuates the vasodilator action of bradykinin in the human forearm. , 1994, British journal of clinical pharmacology.
[23] T. Wascher,et al. Endothelial dysfunction in hypertension , 1994, The Lancet.
[24] T. Cocks,et al. Evidence for differential roles of nitric oxide (NO) and hyperpolarization in endothelium‐dependent relaxation of pig isolated coronary artery , 1994, British journal of pharmacology.
[25] R. Busse,et al. Signal transduction in endothelium-dependent vasodilatation. , 1993, European heart journal.
[26] R. Feldman,et al. Insulin-mediated vasodilation: impairment with increased blood pressure and body mass , 1993, The Lancet.
[27] J. McEwan,et al. Bradykinin‐induced release of PGI2 from aortic endothelial cell lines: responses mediated selectively by Ca2+ ions or a staurosporine‐sensitive kinase , 1993, British journal of pharmacology.
[28] J. McEwan,et al. Differential sensitivities of the prostacyclin and nitric oxide biosynthetic pathways to cytosolic calcium in bovine aortic endothelial cells , 1992, British journal of pharmacology.
[29] G. Rubanyi. Endothelium‐derived relaxing and contracting factors , 1991, Journal of cellular biochemistry.
[30] M. Mulvany,et al. Mechanical properties of vascular smooth muscle cells in situ , 1976, Nature.
[31] W. Kannel,et al. Risk stratification in hypertension: new insights from the Framingham Study. , 2000, American journal of hypertension.
[32] T. Awata,et al. Insulin levels during fasting and the glucose tolerance test and Homa's index predict subsequent development of hypertension , 2000, Journal of hypertension.
[33] J. Connell,et al. Insulin-mediated vasodilation and glucose uptake are functionally linked in humans. , 1999, Hypertension.
[34] M. Clark,et al. Role of blood flow in the regulation of muscle glucose uptake. , 1997, Annual review of nutrition.
[35] J. T. ter Maaten,et al. Renal handling of urate and sodium during acute physiological hyperinsulinaemia in healthy subjects. , 1997, Clinical science.